QTRX · Quanterix Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · QTRX

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$138.90M	$137.42M	$122.37M	$105.52M	$110.56M	$86.38M
Cost of Revenue	$73.94M	$54.32M	$51.72M	$58.72M	$48.83M	$38.20M
Gross Profit	$64.96M	$83.10M	$70.65M	$46.81M	$61.73M	$48.18M
R&D	$35.92M	$31.08M	$24.86M	$25.89M	$27.98M	$20.17M
SG&A	$138.01M	$101.62M	$90.24M	$92.00M	$92.34M	$59.59M
Total Operating Expenses	$190.50M	$135.72M	$120.35M	$148.51M	$120.31M	$79.77M
D&A	$7.00M	$4.80M	$4.70M	$3.50M	$2.80M	$2.20M
Operating Income	($125.54M)	($52.62M)	($49.70M)	($101.70M)	($58.59M)	($31.58M)
Interest Expense	-	-	-	-	-	-
Income Tax	($5.12M)	$434.0K	$719.0K	$65.0K	($36.0K)	($376.0K)
Net Income	($107.15M)	($38.53M)	($32.33M)	($96.70M)	($57.69M)	($31.53M)
EPS - Basic	($2.51)	($1.00)	($0.86)	($2.61)	($1.07)	-
EPS - Diluted	($2.51)	($1.00)	($0.86)	($2.61)	($1.63)	($1.07)

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$29.84M	$56.71M	$174.42M	$338.74M	$396.46M	$181.58M
Accounts Receivable	$29.97M	$32.14M	$25.41M	$19.02M	$23.79M	$17.18M
Inventory	$54.76M	$32.77M	$22.36M	$16.79M	$22.19M	$14.86M
Accounts Payable	$13.57M	$6.95M	$5.05M	$3.84M	$9.21M	$6.80M
Current Assets	$212.26M	$363.59M	$378.39M	$381.40M	$448.95M	$219.60M
Total Assets	$418.77M	$406.53M	$425.01M	$434.20M	$501.53M	$271.05M
Current Liabilities	$74.76M	$42.01M	$38.46M	$30.96M	$36.98M	$39.80M
Long-term Debt	-	-	-	-	-	$7.69M
Total Liabilities	$123.04M	$76.50M	$78.23M	$75.26M	$60.58M	$64.92M
Stockholders' Equity	$295.73M	$330.04M	$346.93M	$358.94M	$440.95M	$206.13M
Retained Earnings	($577.23M)	($470.08M)	($434.50M)	($402.16M)	($305.46M)	($247.77M)

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	($77.24M)	($35.16M)	($18.90M)	($48.27M)	($47.91M)	($23.36M)
Investing Cash Flow	$50.23M	($82.27M)	($148.40M)	($11.21M)	($6.34M)	($626.0K)
Financing Cash Flow	($708.0K)	$456.0K	$2.69M	$2.31M	$270.80M	$96.24M
CapEx	$2.61M	$3.37M	$3.79M	$11.73M	$13.62M	$3.93M
Free Cash Flow	($79.85M)	($38.53M)	($22.69M)	($60.00M)	($61.52M)	($27.30M)

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	46.8%	60.5%	57.7%	44.4%	55.8%	55.8%
Operating margin	-90.4%	-38.3%	-40.6%	-96.4%	-53.0%	-36.6%
EBITDA margin	-85.3%	-34.8%	-36.8%	-93.1%	-50.5%	-34.0%
Net margin	-77.1%	-28.0%	-26.4%	-91.6%	-52.2%	-36.5%
Free cash flow margin	-57.5%	-28.0%	-18.5%	-56.9%	-55.6%	-31.6%
FCF / Net income	0.75	1.00	0.70	0.62	1.07	0.87
R&D / Revenue	25.9%	22.6%	20.3%	24.5%	25.3%	23.4%
SG&A / Revenue	99.4%	73.9%	73.7%	87.2%	83.5%	69.0%
Effective tax rate	-	-	-	-	-	-
Return on assets	-25.6%	-9.5%	-7.6%	-22.3%	-11.5%	-11.6%
Return on equity	-36.2%	-11.7%	-9.3%	-26.9%	-13.1%	-15.3%
Return on invested capital	-	-	-	-	-	-11.7%
Liquidity
Current ratio	2.84	8.66	9.84	12.32	12.14	5.52
Quick ratio	2.11	7.88	9.26	11.78	11.54	5.14
Cash ratio	0.40	1.35	4.54	10.94	10.72	4.56
Leverage
Debt / Equity	-	-	-	-	-	0.04
Debt / Assets	-	-	-	-	-	0.03
Debt / EBITDA	-	-	-	-	-	-
Interest coverage	-	-	-	-	-	-
Equity multiplier	1.42	1.23	1.23	1.21	1.14	1.31
Liabilities / Assets	0.29	0.19	0.18	0.17	0.12	0.24
Efficiency
Asset turnover	0.33	0.34	0.29	0.24	0.22	0.32
Inventory turnover	1.35	1.66	2.31	3.50	2.20	2.57
Days sales outstanding	79d	85d	76d	66d	79d	73d
Days inventory outstanding	270d	220d	158d	104d	166d	142d
Days payable outstanding	67d	47d	36d	24d	69d	65d
Cash conversion cycle	282d	259d	198d	146d	176d	150d
Valuation
P / E	-	-	-	-	-	-
P / B	0.9x	1.2x	3.0x	1.4x	2.4x	6.7x
P / S	2.0x	3.0x	8.4x	4.9x	9.6x	15.9x
EV / EBITDA	-	-	-	-	-	-
Growth
Revenue growth (YoY)	1.1%	12.3%	16.0%	-4.6%	28.0%	277.6%
Revenue CAGR (3y)	9.6%	7.5%	12.3%	66.5%	84.6%	-
Revenue CAGR (5y)	10.0%	43.1%	47.4%	-	-	-
Gross profit growth (YoY)	-21.8%	17.6%	50.9%	-24.2%	28.1%	79.5%
Operating income growth (YoY)	-138.6%	-5.9%	51.1%	-73.6%	-85.5%	24.1%
Net income growth (YoY)	-178.1%	-19.2%	66.6%	-67.6%	-83.0%	22.7%
EPS growth (YoY)	-151.0%	-16.3%	67.0%	-60.1%	-52.3%	-
EPS CAGR (3y)	-	-	-	-	-	-
EPS CAGR (5y)	-	-	-	-	-	-
FCF growth (YoY)	-107.2%	-69.8%	62.2%	2.5%	-125.4%	26.3%
FCF CAGR (5y)	-	-	-	-	-	-
Book value growth (YoY)	-10.4%	-4.9%	-3.3%	-18.6%	113.9%	-

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$138.65M total

Reportable Segment$138.65M · 100.0%

Product / service

$359.59M total

Product$92.94M · 25.8%

Simoa Product Revenue$71.03M · 19.8%

Service And Other Revenue$44.21M · 12.3%

Consumable And Other Products$42.05M · 11.7%

Simoa Service And Other Revenue$32.39M · 9.0%

Research Services$23.68M · 6.6%

Spatial Product Revenue$21.91M · 6.1%

Spatial Service And Other Revenue$11.82M · 3.3%

Instrument Products$7.04M · 2.0%

Service Type Warranties$6.27M · 1.7%

Other Services$4.51M · 1.3%

License And Service$1.50M · 0.4%

Grant$243.0K · 0.1%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

-0.52

Distress

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

1/9

Weak

✗Net income positive
✗Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
-Long-term debt decreased
✗Current ratio improved
✗No share dilution
✗Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Laboratory Analytical Instruments

Company	Revenue (last FY)	Net margin	ROE
AVTR	$6.55B	-8.1%	-9.5%
ILMN	$4.34B	19.6%	31.2%
A	-	-	-
CTKB	$201.49M	-33.0%	-19.5%
EYPT	$31.37M	-739.4%	-75.8%

Comparing Quanterix Corp against the 5 most active filers in the same SIC group.